The Genetic Alteration of P16 and CDK4 Genes and Their Relations to HBV Infection in Human Hepatocellular Carcinoma

王辉云,严瑞琪,吴秋良,龙江斌,梁启万

DOI: https://doi.org/10.3760/j.issn:0254-1432.1999.01.008

1999-01-01

Abstract:Objective To explore the genetic alterations of the tumor suppressor gene p16 and oncogene CDK4,as well as their relations to HBV infection during the developmental process of human hepatocellular carcinoma (HCC).Methods 40 cases of fresh paired tumor and nontumor liver tissues obtained from surgical resections were used for genetic analysis of p16,CDK4 and HBV DNA with Southern blot and hybridization. These samples were also examined histologically.Results The homozygous deletions of p16 gene were detected in 4 of 36 cases and hemizygous deletions in another 3 cases. The frequency of p16 deletion was 19.4%.About one third of p16 deletion was found in HCCs with tumor size5cm.The deletion of p16 was not correlated with the integration of HBV DNA.CDK4 amplifications were detected in 5 of 37 cases (13.2%),and the gene amplifications and p16 deletions did not appear in the same case. All of the cases with CDK4 amplifications were detected in the HCCs with HBV DNA integration. The majority of amplifications were observed in HCCs with poorer differentiation, higher index of mitosis and larger size.Conclusion p16 deletion might play certain important role in a subset of HCCs and didn’t correlate with the HBV DNA integration;CDK4 amplification could be correlated with HBV DNA integration and the progression of HCC.